Skip to main content
Amicogen, Inc. logo

Amicogen, Inc. - Investor Relations & Filings

Listed IPO Sep 2013
Ticker · 092040 ISIN · KR7092040005 LEI · 549300TN7B5XAO5U1H84 KO Manufacturing
Open in API
Filings indexed 418 across all filing types
Latest filing 2025-03-11 Earnings Release
Country KR South Korea
Listing KO 092040 · 1 venue

Key figures FY2025

Period ended 2025-12-31 · KRW
Headline annual figures for Amicogen, Inc., fiscal year 2025, reported in KRW, with the source filing for each figure.
Total Revenues KRW 40.52B per the Audit Report / Information filed 2026-04-30
Net Income KRW -23.49B per the Audit Report / Information filed 2026-04-30
Total Assets KRW 197.47B per the Audit Report / Information filed 2026-04-30
Total Equity KRW 111.14B per the Audit Report / Information filed 2026-04-30
Cash from Ops KRW -19.28B per the Audit Report / Information filed 2026-04-30

As reported by the issuer in the filings linked above. Figures are normalized for comparability; consult the source filing for the authoritative statement.

About Amicogen, Inc.

http://amicogen.com/en/

Amicogen, Inc. is an industrial biotechnology company specializing in the development and production of specialty enzymes and proteins. The company operates across three primary business areas: Enzyme and Biopharmaceuticals, Healthcare and Nutrition, and Bioprocess and CDMO (Contract Development and Manufacturing Organization) services. Leveraging its proprietary enzyme technology, Amicogen creates innovative solutions for the biopharmaceutical, food, and cosmetics industries. The healthcare division develops and manufactures functional food ingredients and nutritional products. The company also provides bioprocess solutions, including protein purification resins and comprehensive CDMO services to support the biopharmaceutical sector.

Recent filings

Filing Released Lang Actions
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release Classification · 100% confidence The document is a regulatory filing from Amicogen regarding a significant change in revenue or profit/loss structure (30% or more). It provides a comparative table of financial results (revenue, operating profit, net income) between the current and previous fiscal years, explains the reasons for the change, and notes that these are preliminary figures subject to audit. This fits the definition of an Earnings Release (ER) as it is an initial announcement of financial results highlights. FY 2024
2025-03-11 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership by a major shareholder (Shin Yong Chul) in Amicogen Inc. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema, as it tracks significant changes in ownership levels.
2025-03-07 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service. It details the share acquisition (장내매수) by an executive (Kim Jun-ho) of Amicogen Inc. This type of filing is specifically categorized as a 'Director's Dealing' (DIRS) report, as it documents insider transactions by company management.
2025-02-28 Korean
임시주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an official announcement of the results of an Extraordinary General Meeting (EGM) held on February 26, 2025. It details the voting outcomes for various agenda items, including the dismissal and appointment of directors and amendments to the articles of association. This falls directly under the category of Declaration of Voting Results & Voting Rights Announcements.
2025-02-26 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership by a major shareholder (Shin Yong Chul) and their special related parties, including reasons for the change such as collateral execution (margin calls) and changes in special relationships. This falls under the category of Major Shareholding Notification.
2025-02-26 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). It details the share transactions (specifically '장내매도' or on-market sales) by a director (Shin Yong Chul) of Amicogen Inc. This type of filing is a standard regulatory requirement for insider trading/shareholding changes by company executives, which corresponds to the 'Director's Dealing' category.
2025-02-26 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.